Melanoma March Update
13 March 2020
MELANOMA MARCH - CANCELLATION OF EVENTS
Statement from Melanoma Institute Australia CEO Matthew Browne
Due to the escalating impact of COVID-19, and in the interests of the health and safety of all participants and attendees, we have made the difficult decision to cancel all remaining Melanoma March events nationally. This includes the seven events scheduled for this weekend - Melbourne, Bunbury, Bendigo, Coolangatta, Macarthur, Mackay, and Wagga Wagga.
This decision has not been made lightly, however protecting the health of our dedicated community members and their families who run and attend these events, many of whom are cancer patients, is paramount.
We will be offering full refunds for registrations. (See below).
We are planning to hold a virtual Melanoma March event on Sunday 29th March to enable our community across Australia to still come together as we have done for Melanoma March for the last 9 years. We will provide more detail regarding this very soon.
My sincere apologies and thanks particularly to our volunteer committees who work tirelessly to put on their local Melanoma March events every year.
UPDATE ON REFUNDS
If you would like a refund for your Melanoma March event registration, please email email@example.com. Otherwise, all registration fees will go towards our overall Melanoma March tally. We are of course still gratefully accepting donations on the Melanoma March website to support development of the national matched immunotherapy platform. Your ongoing support and understanding is greatly appreciated.
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
A round of applause for a well deserved win.
A message from our CEO, Carole Renouf
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.